- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ascletis Pharma Inc (1672)
Ascletis Pharma Inc stock price live, this page displays HK 1672 stock exchange data. View the 1672 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ascletis Pharma Inc real time stock price chart below.
What Is the Ascletis Pharma Inc Stock Price Today?
The Ascletis Pharma Inc stock price today is 4.78.
What Is the Stock Symbol for Ascletis Pharma Inc?
The stock symbol for Ascletis Pharma Inc is "1672."
What Stock Exchange Does Ascletis Pharma Inc Trade On?
Ascletis Pharma Inc is listed and trades on the Hong Kong stock exchange.
Is Ascletis Pharma Inc a Good Stock to Buy?
Determining whether Ascletis Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1672 quote. (ISIN: KYG0520K1094)
What Is the Ascletis Pharma Inc Stock Price Today?
The Ascletis Pharma Inc stock price today is 4.78.
What Is the Stock Symbol for Ascletis Pharma Inc?
The stock symbol for Ascletis Pharma Inc is "1672."
What Stock Exchange Does Ascletis Pharma Inc Trade On?
Ascletis Pharma Inc is listed and trades on the Hong Kong stock exchange.
Is Ascletis Pharma Inc a Good Stock to Buy?
Determining whether Ascletis Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1672 quote. (ISIN: KYG0520K1094)
4.78
+0.07(+1.49%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.78
4.87
52 wk Range
4.12
19.86
1672 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.784.87
52 wk Range
4.1219.86
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1672 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
22.59
Upside
+372.51%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 22.59
(+372.51% Upside)
Earnings
Latest Release
Aug 31, 2026
EPS / Forecast
-0.15 / --
Revenue / Forecast
-- / --
Compare 1672 to Peers and Sector
Metrics to compare | 1672 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1672PeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.2x | −7.6x | −0.2x | |
PEG Ratio | 0.06 | 0.06 | 0.00 | |
Price/Book | 1.9x | 2.7x | 2.6x | |
Price / LTM Sales | 4,473.3x | 12.9x | 2.8x | |
Upside (Analyst Target) | 368.7% | 57.1% | 60.9% | |
Fair Value Upside | Unlock | 4.1% | 9.5% | Unlock |
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Further, it offers ASC30, for obesity; ASC47 for muscle-preserving weight loss treatment; and ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist. Ascletis Pharma Inc. was founded in 2013 and is based in Wan Chai, Hong Kong.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ascletis Pharma (1672) Stock Price Today?
The Ascletis Pharma stock price today is 4.78 HKD.
What Stock Exchange Does Ascletis Pharma Trade On?
Ascletis Pharma is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Ascletis Pharma?
The stock symbol for Ascletis Pharma is "1672."
What Is the Ascletis Pharma Market Cap?
As of today, Ascletis Pharma market cap is 5.06B HKD.
What Is Ascletis Pharma's Earnings Per Share (TTM)?
The Ascletis Pharma EPS (TTM) is -0.68.
From a Technical Analysis Perspective, Is 1672 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ascletis Pharma Stock Split?
Ascletis Pharma has split 0 times.
How Many Employees Does Ascletis Pharma Have?
Ascletis Pharma has 217 employees.
What is the current trading status of Ascletis Pharma (1672)?
As of Nov 10, 2026, Ascletis Pharma (1672) is trading at a price of 4.78 HKD, with a previous close of 4.71 HKD. The stock has fluctuated within a day range of 4.78 HKD to 4.87 HKD, while its 52-week range spans from 4.12 HKD to 19.86 HKD.
What Is Ascletis Pharma (1672) Price Target According to Analysts?
The average 12-month price target for Ascletis Pharma is 22.59 HKD, with a high estimate of 31.21578762 HKD and a low estimate of 13.95630213 HKD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +372.51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.